##
##
||||||Pages|
|---|---|---|---|---|---|
|Charity Reference and|Administrative|Details|||3-4|
|Trustees'
Annual
Report|||||5-11|
|Independent
Examiner's
Report|||||12- 13|
|Statement ofFinancial|Activities (including||Income and Expenditure|Account)|14|
|Balance Sheet|||||15|
|Statement ofCashflows|||||16|
|Notes to the Financial|Statements||||17-27|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
#
#
##
||||2021|2020|
|---|---|---|---|---|
||||Unrestricted|Unrestricted|
||||Funds|Funds|
|||Note|f||
|Income from:|||||
|Voluntary
income|||429,446|1,083,423|
|Investment
income|||23,947|27,867|
|Total income and|endowments||453,393|1,111,290|
|Expenditure
on:|||||
|Generating
funds|||189,988|303,435|
|Charitable
activities|||155,000|240,000|
|Total expenditure|||344,988|543,435|
|Net income/(expenditure)|||108,405|567,855|
|Net gains / (losses)|on investments||31,591|(46,563)|
|Net movement
in|funds|16|139,996|521,292|
|Reconciliation offunds:|||||
|Total funds brought|forward|16|2,135,768|1,614,476|
|Total funds carried forward||16|2,275,764|2,135,768|
##
##
##
##
|||||2021|2020|
|---|---|---|---|---|---|
||||Note|||
|Cash flow from operating|activities||17|59,379|422,692|
|Net cash flow from operating||activities||59,379|422,692|
|Cash flow from investing|activities|||||
|Payments
to acquire investments||||(28,632)|(46,555)|
|Receipts from sales ofinvestments||||28,719|52,417|
|Interest received||||8,103|8,745|
|Dividends
received||||15,844|19,122|
|Net cash flow from investing||activities||24,034|33,729|
|Net (decrease)/increase
in|cash and cash equivalents|||83,413|456,421|
|Cash and cash equivalents|at|I April 2020||1,951,813|1,495,392|
|Cash and cash equivalents|at|31March 2021||2,035,226|1,951,813|
|Cash and cash equivalents|consists of:|||||
|Current account||||23,339|4,107|
|Money market deposits||||1,537,254|1,479,830|
|Broker's account||||7,579|9,255|
|Deposit account||||267,784|262,660|
|Charity
bonds||||199,270|195,961|
|Cash at bank and in hand|at|31March 2021||2,035,226|1,951,813|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||||2021
f|2020f|
|---|---|---|---|---|---|
||General
donations|||225,150|215,301|
||Events||||158,489|
||In memoriam|||37,657|19,146|
||Collecting boxes||||3,071|
||Regular giving|||8,105|7,623|
||University ofLeicester|||8,472|8,472|
||Accommodation|in kind||6,000|6,000|
||Greetings
cards|||214|1,284|
||Christmas jumpers||||1,091|
||Books|||1,274||
||Tax refund|||18,687|48,572|
||University ofLoughborough||||1,569|
||Capital appeal|||123,887|612,805|
|||||429,446|1,083,423|
|All|voluntary
income received||in 2020 and 2021 is unrestricted.|||
|3|Investment
income|||||
|||||2021f|2020f|
||Bank interest|||8,103|8,745|
||Share dividends|||15,844|19,122|
|||||23,947|27,867|
##
|||Note|2021f|2020|
|---|---|---|---|---|
|General costs|||180,747|233,196|
|Events|||(1,199)|45,387|
|Accommodation|||6,000|6,000|
|Greetings|cards|||336|
|Christmas|jumpers|||3,368|
|Books||||1,992|
|Capital appeal costs|||4,440|13,156|
||||189,988|303,435|
##
##
##
|||||2021f|2020
f|
|---|---|---|---|---|---|
|Staff costs||||113,075|148,260|
|Staff and volunteer||training||489|900|
|Staff and volunteer||recruitment||613||
|Equipment||||8,912|11,973|
|Utilities||||1,691|1,573|
|Postage and stationery||||4,799|5,876|
|Telephone
and|internet||charges|1,588|2,082|
|Insurance||||2,003|2,077|
|Marketing||||24,895|30,226|
|Travel expenses||||83|3,270|
|Bank charges||||387|1,139|
|Subscriptions||||1,885|1,853|
|Depreciation||||1,461|1,460|
|Miscellaneous||||3,268|4,619|
|Administrative|costs|||10,835|14,809|
|Legal and professional|||fees|3,000|1,200|
|Investment
management|||fees|1,763|1,879|
|||||180,747|233,196|
##
##
##
##
|Analysis ofgrants||||
|---|---|---|---|
||Period of
award|2021f|2020f|
|CTFNurse 2021/22|2021/2022|40,000||
|LCRC 2021/22|2021/2022|115,000||
|CTFNurse 2019/20|2019/2020||40,000|
|CTFNurse 2020/21|2020/2021||40,000|
|LCRC 2019/20|2019/2020||160,000|
|||155,000|240,000|
||||2021|||2020|
|---|---|---|---|---|---|---|
||Due|Due after||Due|Due after||
||within
one|more than||within
one|more than||
||yearf|one yearf|Total due|year
K|one year|Total duef|
|Dr Chris Talbot|||||||
|(Breast Cancer)|14321||14421|23,000|12,324|35324|
|Dr Lynn Furber|||||||
|(Breast Cancer)|22,680||22,680|20,000|23,163|43,163|
|CTFNurse 2018/19|647||647|647||647|
|LCRC 2018/19||||5,000||5,000|
|CTFNurse 2019/20||||10,000||10,000|
|CTFNurse 2020/21|40,000||40,000|40,000||40,000|
|CTFNurse 2021/22|40,000||40,000||||
|LCRC-2019/20||||144,988||144,9SS|
|LCRC- 2021/22|115,000||115,000||||
||232,648||232,648|243,635|35,487|279,122|
##
##
##
##
##
|Tangible fixed assets|||||
|---|---|---|---|---|
||Fixtures|and|Computer||
||fittings
f||equipment
f|Total
f|
|Cost or valuation:|||||
|At I April 2020&31|||||
|March 2021||4,803|5,448|10,251|
|Depreciation:|||||
|At I April 2020||3,281|4,948|8,229|
|Charge for the year||961|500|1,461|
|At 31 March 2021||4,242|5,448|9,690|
|Net book value:|||||
|At 31 March 2020||1,522|500|2,022|
|At 31 March 2021||561||561|
##
|11|Fixed asset investments||||
|---|---|---|---|---|
||||2021|2020|
||||f||
||Market value at I April 2020||473,237|525,662|
||Acquisitions
at cost||28,632|46,555|
||Sales proceeds from disposals||(28,719)|(52,417)|
||Net gains/(losses)
on revaluation|in the year|31,590|(46,563)|
||Market value at 31 March 2021||504,740|473,237|
||Historical
cost as at 31 March 2021||165,294|169,305|
||Investments
at fair value compromise:||||
||||2021
f|2020f|
||Listed investments
in the UK||380,457|392,053|
||Listed investments
outside the UK||124,283|81,184|
||||504,740|473,237|
##
|Debtors||||||
|---|---|---|---|---|---|
|||||2021f|2020f|
|Prepayments|and|accrued|income|21,427|16,010|
|||||21,427|16,010|
##
##
##
|||||2021
f|2020f|
|---|---|---|---|---|---|
||Other tax|and social security||3,401|3,799|
||Accruals|for grants|payable (Note 7)|232,648|243,635|
||Accruals|||2,381|6,753|
||Deferred|income (Note 15)||47,760|17,640|
|||||286,190|271,827|
|14|Creditors: amounts
falling due after more than one year|||||
|||||2021f|2020f|
||Accruals|for grants|payable (Note 7)||35,487|
||||||35,487|
|15|Deferred|income||||
|||||2021f|2020|
||At 1 April|2020||17,640|26,641|
||Additions|during the year||39,280|17,640|
||Amounts|released to income||(9,160)|(26,641)|
||At 31 March 2021|||47,760|17,640|
##
##
|2020|||||||
|---|---|---|---|---|---|---|
||Balance at||||Gains /|Balance at|
||I April|Income|Expenditure|Transfers|(losses)|31March|
||2019||f|f||2020f|
|Undesignated|954,202|498,485|(530,279)||(46,563)|875,845|
|Designated|660,274|612,805|(13,156)|||1,259,923|
|Unrestricted|1,614,476|1,111,290|(543,435)||(46,563)|2,135,768|
|021|||||||
|---|---|---|---|---|---|---|
||Balance at||||Gains /|Balance at|
||IApril|Income|Expenditure|Transfers|(losses)|31March|
||2020|f||||2021
f|
|Undesignated|875,845|323,505|(332,784)||29,828|896,394|
|Designated|1,259,923|123,887|(4,440)|||1,379,370|
|Unrestricted|2,135,768|447,392|(337,224)||29,828|2,275,764|
##
##
##
||||2021
f|2020
f|
|---|---|---|---|---|
|Surplus/(deficit)
for
Depreciation
(Increase)/decrease
Increase/(decrease)
Increase/(decrease)
Interest received|the year
in debtors
in creditors
in creditors|due within one year
due after more than one year|139,996
1,461
(5,417)
14,363
(35,487)|521,292
1,460
5,412
(115,869)
(8,299)|
|Dividends
received|||(8,103)|(8,745)|
|Investment
(gain)/loss|||(15,844)
(31,590)|(19,122)
46,563|
||||59,379|422,692|